Global   US   France   Germany   Spain   Brazil   Poland   Rusia   Netherlands   Australia   Canada   China   UK   Taiwan   Hongkong   Austria   Mexico   Turkey   Italy   Portugal   Sweden   Japan   Switzerland   Argentina   Korea   Indonesia   Philipine   Norway   India   Israel   Grrek   Thai  

asia pacific - News Reader PRO

Asia-Pacific Currencies Weekly Recap: High-Flying Aussie, Kiwi Drilled Lower Amid Bond Market Rout


The U.S. Dollar rose against the Asia-Pacific currencies last week, lifted by an increase in U.S. bond yields, which drove down demand for the Japanese Yen and the higher-risk Australian and New Zealand Dollars.

Government bonds, and particularly U.S. Treasuries, have become the focal point of markets globally. Traders have moved aggressively to price in earlier monetary tightening than the Federal Reserve and other central banks have signaled, Reuters said.

Bond yields have climbed this year on the outlook for massive fiscal stimulus amid continued ultra-easy monetary policy, led by the United States. At this time last year, more U.S. fiscal stimulus on top of the already existing loose Fed monetary policy, would’ve sent the U.S. Dollar tumbling. In fact, most forecasts since late last year highlighted these two reasons as the key factors that would keep the pressure on the greenback.

However, with the U.S. economy strengthening, investors now believe that cheap money and more stimulus would speed up the economic recovery, leading to a jump in inflation. Investors are selling bonds in anticipation of higher inflation, driving up interest rates while making the U.S. Dollar a more attractive asset.

Furthermore, rising yields have dampened the appeal of higher risk assets, particularly the Australian and New Zealand Dollar, which are closely linked to overpriced commodities.

Japanese Yen

The Dollar/Yen gained last week, touching its highest level since August 28. Both the dollar and yen are considered safe-haven currencies, but the Yen tends to decline when U.S. yields rise, the dollar tends to strengthen.

Essentially, it was the widening spread between U.S. Government bond yields and Japanese Government bond yields that made the U.S. Dollar a more attractive investment.

Last week, the USD/JPY settled at 106.549, up 1.125 or +1.07%.

Australian Dollar

The Australian Dollar took a hit last week, drilled lower from multi-year peaks as a rout in bond markets spread to other risk assets, spurring the country’s central bank to intervene to stem a savage selloff in government debt.

Story continues

The Aussie had been flying high throughout the week as it jumped the .8000 barrier for the first time since February 2018, but reality came back with a vengeance when investors started to dump higher risk commodities and equities.

Last week, the AUD/USD settled at .7704, down 0.0165 or -2.10%.

At one point on Friday, Australian 10-year bond futures were down as much as 23 ticks at an 11-month low of 98.0450, before bouncing to 98.2600. That still left them nursing losses of 30 ticks for the week, the sharpest drop since mid-2015, according to Reuters.

The selling pressure became so intense the Reserve Bank of Australia (RBA) launched an unscheduled offer to buy A$3 billion ($2.36 billion) in three-year debt. That seemed to calm markets a little and three-year yields eased back to 0.127% from 0.157%.

Markets were also wagering the RBA might have to hike rates as early as next year, even when policy makers have said no move was likely until 2024 at the earliest.

New Zealand Dollar

The New Zealand Dollar posted a volatile two-sided trade last week before settling sharply lower. The Kiwi rallied to a multi-year high early in the week after the Reserve Bank of New Zealand (RBNZ) kept monetary policy on hold and said inflation and employment will remain below its targets in the medium term.

The RBNZ also expressed some caution about the outlook, which may have disappointed some traders who expected central bankers to acknowledge a recent improvement in economic data.

The Kiwi plunged late in the week along with the other higher risk assets after a surge in Treasury yields drove investors into the U.S. Dollar.

Last week, the NZD/USD settled at .7233, down 0.0064 or -0.88%.

For a look at all of today’s economic events, check out our economic calendar.

This article was originally posted on FX Empire

More From FXEMPIRE:

Source: Asia-Pacific Currencies Weekly Recap: High-Flying Aussie, Kiwi Drilled Lower Amid Bond Market Rout

Noteworthy Investment for Asia Pacific Syringe Market is expected to grow US$ 5,946.66 million by 2027


Asia Pacific syringe market is projected to reach US$ 5,946.66 million by 2027 from US$ 2,654.58 million in 2019. The market is estimated to grow at CAGR of 10.5% from 2020 to 2027.

The growth of the market is driven by the factors such as, growing number of chronic diseases and infectious diseases and increased adoption of injectable drugs. However, the market is likely to have negative impact due to growing cases of needle-stick injuries.

A syringe is a piston-like medical instrument that has a significant importance in healthcare. Syringes play a major role in administration of vaccines, nutritional supplements, and medicines. The product has wide range of applicability, from injecting of liquid nutritionals into a feeding tube to conduct vaccination. Syringes can be classified into reusable and disposables. Increasing prevalence of chronic conditions and rising patient population is prominently expected to drive the market growth during the forecast period.

Get Sample Copy of this Asia Pacific Syringe Market research report at - https://www.businessmarketinsights.com/sample/TIPRE00015145

The segmentation of the Asia Pacific Syringe Market by type, application, and region was done based on the thorough market analysis and validation through extensive primary inputs from industry experts, key opinion leaders of companies, and stakeholders) and secondary research (regional/regional associations, trade journals, technical white papers, company’s website, annual report SEC filing, and paid databases). Further, the market has been estimated by utilizing various research methodologies and internal statistical model.

The report profiles the key players in the industry, along with a detailed analysis of their individual positions against the regional landscape. The study conducts SWOT analysis to evaluate strengths and weaknesses of the key players in the Asia Pacific Syringe market. The researcher provides an extensive analysis of the Asia Pacific Syringe market size, share, trends, overall earnings, gross revenue, and profit margin to accurately draw a forecast and provide expert insights to investors to keep them updated with the trends in the market.

Browse Full Report With TOC @https://www.businessmarketinsights.com/reports/asia-pacific-syringe-market

Major key players covered in this report:•BD•Baxter International Inc.•Terumo Corporation•Cardinal Health Inc.•Nipro•B. Braun Melsungen AG

The study conducts SWOT analysis to evaluate strengths and weaknesses of the key players in the Asia Pacific Syringe market. Further, the report conducts an intricate examination of drivers and restraints operating in the market. The report also evaluates the trends observed in the parent market, along with the macro-economic indicators, prevailing factors, and market appeal with regard to different segments. The report predicts the influence of different industry aspects on the Asia Pacific Syringe market segments and regions.

Order a Copy of this Asia Pacific Syringe Market research report at – https://www.businessmarketinsights.com/buy/single/TIPRE00015145

The research on the Asia Pacific Syringe market focuses on mining out valuable data on investment pockets, growth opportunities, and major market vendors to help clients understand their competitor’s methodologies. The research also segments the Asia Pacific Syringe market on the basis of end user, product type, application, and demography for the forecast period 2020–2027. Comprehensive analysis of critical aspects such as impacting factors and competitive landscape are showcased with the help of vital resources, such as charts, tables, and infographics.

This report strategically examines the micro-markets and sheds light on the impact of technology upgrades on the performance of the Asia Pacific Syringe market.

Contact US:Business Market InsightsPhone: +442081254005E-Mail ID: sales@businessmarketinsights.comWeb URL: https://www.businessmarketinsights.com/Linkedin URL: https://www.linkedin.com/company/business-market-insights/

About Us:Based in New York, Business Market Insights is a one-stop destination for in-depth market research reports from various industries including Technology, Media & Telecommunications, Semiconductor & Electronics, Aerospace & Defense, Automotive & Transportation, Biotechnology, Healthcare IT, Manufacturing & Construction, Medical Device, and Chemicals & Materials. The clients include corporate and academic professionals, consulting, research firms, PEVC firms, and professional services firms.

This release was published on openPR.


Source: Noteworthy Investment for Asia Pacific Syringe Market is expected to grow US$ 5,946.66 million by 2027

Remarkable Asset Knocking in Asia Pacific Medical Cyclotron Market Industry is expected to grow US$ 51.45 by 2027


Medical Cyclotron

Medical Cyclotron

The Asia Pacific medical cyclotron market is expected to reach US$ 51.45 million to 2027 from US$ 37.34 million in 2019, it is estimated to grow with a CAGR of 4.2% from 2020 to 2027.

A cyclotron is an electrically powered machine that produces a beam of charged particles for industrial, research, and medical purposes. In medical applications, cyclotrons have rays that are used to manufacture radioisotopes for medical imaging. Various medical cyclotrons are being used for the production of SPECT and Positron Emission Tomography (PET) isotopes used for therapeutic and other medical applications.

Get Sample Copy of this Asia Pacific Medical Cyclotron Market research report at - https://www.businessmarketinsights.com/sample/TIPRE00019057

The segmentation of the Asia Pacific Medical Cyclotron Market by type, application, and region was done based on the thorough market analysis and validation through extensive primary inputs from industry experts, key opinion leaders of companies, and stakeholders) and secondary research (regional/regional associations, trade journals, technical white papers, company’s website, annual report SEC filing, and paid databases). Further, the market has been estimated by utilizing various research methodologies and internal statistical model.

The report profiles the key players in the industry, along with a detailed analysis of their individual positions against the regional landscape. The study conducts SWOT analysis to evaluate strengths and weaknesses of the key players in the Asia Pacific Medical Cyclotron market. The researcher provides an extensive analysis of the Asia Pacific Medical Cyclotron market size, share, trends, overall earnings, gross revenue, and profit margin to accurately draw a forecast and provide expert insights to investors to keep them updated with the trends in the market.

Browse Full Report With TOC @ https://www.businessmarketinsights.com/reports/asia-pacific-medical-cyclotron-market

Major key players covered in this report:•General Electric Company•Varian Medical Systems, Inc•IBA•Sumitomo Heavy Industries, Ltd.•Siemens AG•Advanced Cyclotron Systems•isoSolution Inc

The study conducts SWOT analysis to evaluate strengths and weaknesses of the key players in the Asia Pacific Medical Cyclotron market. Further, the report conducts an intricate examination of drivers and restraints operating in the market. The report also evaluates the trends observed in the parent market, along with the macro-economic indicators, prevailing factors, and market appeal with regard to different segments. The report predicts the influence of different industry aspects on the Asia Pacific Medical Cyclotron market segments and regions.

Order a Copy of this Asia Pacific Medical Cyclotron Market research report at – https://www.businessmarketinsights.com/buy/single/TIPRE00019057

The research on the Asia Pacific Medical Cyclotron market focuses on mining out valuable data on investment pockets, growth opportunities, and major market vendors to help clients understand their competitor’s methodologies. The research also segments the Asia Pacific Medical Cyclotron market on the basis of end user, product type, application, and demography for the forecast period 2020–2027. Comprehensive analysis of critical aspects such as impacting factors and competitive landscape are showcased with the help of vital resources, such as charts, tables, and infographics.

This report strategically examines the micro-markets and sheds light on the impact of technology upgrades on the performance of the Asia Pacific Medical Cyclotron market.

Contact US:Business Market InsightsPhone: +442081254005E-Mail ID: sales@businessmarketinsights.comWeb URL: https://www.businessmarketinsights.com/Linkedin URL: https://www.linkedin.com/company/business-market-insights/

About Us:Based in New York, Business Market Insights is a one-stop destination for in-depth market research reports from various industries including Technology, Media & Telecommunications, Semiconductor & Electronics, Aerospace & Defense, Automotive & Transportation, Biotechnology, Healthcare IT, Manufacturing & Construction, Medical Device, and Chemicals & Materials. The clients include corporate and academic professionals, consulting, research firms, PEVC firms, and professional services firms.

This release was published on openPR.


Source: Remarkable Asset Knocking in Asia Pacific Medical Cyclotron Market Industry is expected to grow US$ 51.45 by 2027



News Reader Pro Powered by. Full RSS | Disclaimer | Contact Us